The aim of the study was to find out the effect of non-computerized cognitive remediation and risperidonetherapy to improve cognitive function and disability condition in schizophrenia patients. This study was anexperimental research design, with fourteen participants divided into two group as the experimental groupand the control group. The experimental and control groups both received Risperidone. In addition, theexperimental group was given the non-computerized cognitive remediation (CR). The non-computerizedcognitive remediation will be carried out in 12 sessions (3 sessions per week) using mainly paper andpencil tasks and is based on cognitive strategy instruction. Moreover, all samples will be measured forPANSS (Positive and Negative Symptom Scale), WHODAS 2.0 (World Health Organization DisabilityAssessment Schedule), and SCoRS Vi (Schizophrenia Cognition Rating Scales Indonesian Version) scores.As the results, both experimental and control group showed a significant decrease in the SCoRS Vi andWHODAS 2.0 score (p=0.001). However, the experimental group showed greater improvement comparedto the control group. Synergistic effect of Non-computerized Cognitive Remediation and Risperidone canimprove disability condition in schizophrenia patients.